Yochay Bar-Shavit1, Lucie Jaillet2, Pauline Chauvet2, Michel Canis2, Nicolas Bourdel3. 1. Department of Gynecologic Surgery, Clermont-Ferrand University Hospital Estaing, Place Lucie et Raymond Aubrac, Clermont-Ferrand, France; Department of Obstetrics and Gynecology, Sheba Medical Center Tel Hashomer, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 2. Department of Gynecologic Surgery, Clermont-Ferrand University Hospital Estaing, Place Lucie et Raymond Aubrac, Clermont-Ferrand, France; Faculty of Medecine, ALCoV UMR6284, CNRS/Université d'Auvergne, ISIT, Clermont-Ferrand, France. 3. Department of Gynecologic Surgery, Clermont-Ferrand University Hospital Estaing, Place Lucie et Raymond Aubrac, Clermont-Ferrand, France; Faculty of Medecine, ALCoV UMR6284, CNRS/Université d'Auvergne, ISIT, Clermont-Ferrand, France. Electronic address: nicolas.bourdel@gmail.com.
Abstract
OBJECTIVE: To report and visually demonstrate the feasibility of using indocyanine green (ICG) in endometriosis surgery and to discuss potential benefits. DESIGN: ICG fluorescent imaging has been validated to assess tissue perfusion with clinical use in many medical fields, including gynecology and digestive surgery, but has not described in endometriosis surgery for bowel assessment. To our knowledge, there is no validated, objective, intraoperative method to assess the vascularity of the operated bowel in endometriosis surgery, a potentially good indicator for postoperative fistula formation. Our center is conducting a registered clinical trial examining the use of ICG to evaluate the bowel vascularization after endometriosis rectal shaving surgery, and the potential role in reducing fistula rates (Institutional Review Board no 2016-002773-35). SETTING: Tertiary university hospital. PATIENT(S): Three patients undergoing laparoscopic surgery for deep infiltrating endometriosis (DIE) with the use of a rectal shaving procedure. INTERVENTIONS(S): Patients undergoing laparoscopic surgery for DIE with a rectal shaving procedure were injected with ICG intravenously at the end of endometriosis resection. MAIN OUTCOME MEASURES: Visual assessment of the rectal shaving area was assessed as fluoresced or not with the use of a Likert-type scale (0 = no fluorescence; 4 = very good fluorescence). RESULT(S): After ICG injection, all three patients have showed very good fluorescence levels at the rectal shaving area with no adverse reactions. Other uses of ICG are demonstrated throughout the video (vaginal cuff, ureter, and ovary assessment). CONCLUSION(S): ICG fluorescent imaging is feasible in endometriosis surgery, and there is an ongoing trial to determine if its use reduces postoperative fistula formation. CLINICAL TRIAL REGISTRATION NUMBER: NCT03080558.
OBJECTIVE: To report and visually demonstrate the feasibility of using indocyanine green (ICG) in endometriosis surgery and to discuss potential benefits. DESIGN:ICG fluorescent imaging has been validated to assess tissue perfusion with clinical use in many medical fields, including gynecology and digestive surgery, but has not described in endometriosis surgery for bowel assessment. To our knowledge, there is no validated, objective, intraoperative method to assess the vascularity of the operated bowel in endometriosis surgery, a potentially good indicator for postoperative fistula formation. Our center is conducting a registered clinical trial examining the use of ICG to evaluate the bowel vascularization after endometriosis rectal shaving surgery, and the potential role in reducing fistula rates (Institutional Review Board no 2016-002773-35). SETTING: Tertiary university hospital. PATIENT(S): Three patients undergoing laparoscopic surgery for deep infiltrating endometriosis (DIE) with the use of a rectal shaving procedure. INTERVENTIONS(S): Patients undergoing laparoscopic surgery for DIE with a rectal shaving procedure were injected with ICG intravenously at the end of endometriosis resection. MAIN OUTCOME MEASURES: Visual assessment of the rectal shaving area was assessed as fluoresced or not with the use of a Likert-type scale (0 = no fluorescence; 4 = very good fluorescence). RESULT(S): After ICG injection, all three patients have showed very good fluorescence levels at the rectal shaving area with no adverse reactions. Other uses of ICG are demonstrated throughout the video (vaginal cuff, ureter, and ovary assessment). CONCLUSION(S): ICG fluorescent imaging is feasible in endometriosis surgery, and there is an ongoing trial to determine if its use reduces postoperative fistula formation. CLINICAL TRIAL REGISTRATION NUMBER: NCT03080558.
Authors: Luigi Carlo Turco; Giuseppe Vizzielli; Virginia Vargiu; Salvatore Gueli Alletti; Maria De Ninno; Gabriella Ferrandina; Luigi Pedone Anchora; Giovanni Scambia; Francesco Cosentino Journal: Front Oncol Date: 2021-11-15 Impact factor: 6.244
Authors: Antonio Raffone; Diego Raimondo; Alessia Oliviero; Arianna Raspollini; Antonio Travaglino; Marco Torella; Gaetano Riemma; Marco La Verde; Pasquale De Franciscis; Paolo Casadio; Renato Seracchioli; Antonio Mollo Journal: Medicina (Kaunas) Date: 2022-06-13 Impact factor: 2.948
Authors: Joerg Keckstein; Christian M Becker; Michel Canis; Anis Feki; Grigoris F Grimbizis; Lone Hummelshoj; Michelle Nisolle; Horace Roman; Ertan Saridogan; Vasilios Tanos; Carla Tomassetti; Uwe A Ulrich; Nathalie Vermeulen; Rudy Leon De Wilde Journal: Hum Reprod Open Date: 2020-02-12